Morolimumab

From WikiMD.org
Jump to navigation Jump to search

Morolimumab

Morolimumab (pronunciation: mo-ro-li-mu-mab) is a monoclonal antibody designed for the treatment of various autoimmune diseases. It is a type of biologic therapy that targets and neutralizes specific proteins in the body that contribute to the development and progression of autoimmune conditions.

Etymology

The name "Morolimumab" is derived from the International Nonproprietary Names (INN) system for pharmaceutical substances. The "-mab" suffix indicates that it is a monoclonal antibody, while the prefix "Moroli-" does not have a specific meaning and is used for unique identification.

Mechanism of Action

Morolimumab works by binding to specific proteins in the body that are involved in the immune response. By blocking these proteins, it can help to reduce inflammation and slow the progression of autoimmune diseases.

Related Terms

  • Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Autoimmune disease: A condition in which your immune system mistakenly attacks your body.
  • Biologic therapy: Treatment that uses your body's own immune system to fight cancer.
  • Inflammation: A localized physical condition in which part of the body becomes reddened, swollen, hot, and often painful, especially as a reaction to injury or infection.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski